NAUT · Nautilus Biotechnology, Inc.
$1.20
-0.47 (-28.01%)
At close · Jul 28
Market Cap
$210.95M
Shares
127.08M
Nautilus Biotechnology, Inc. Earnings Call Transcripts
Every quarterly earnings call for Nautilus Biotechnology, Inc. (NAUT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY26 · Q2
2026-07-28
Nautilus Q2 2026 Earnings Conference Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-28
Nautilus Biotechnology, Inc. Q1 FY2026 Earnings Call
Confident tone
Commercialization and customer engagement
Voyager platform and broad-scale assay development
Oncology proteoform target
Diluted EPS
$-0.12
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Nautilus Biotechnology, Inc. Q4 FY2025 Earnings Call
Confident tone
Voyager instrument unveiling and early access program
Proteomics platform and proteoform diversity
Tau proteoform assay and collaborations
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Nautilus Biotechnology, Inc. Q3 FY2025 Earnings Call
Confident tone
Tau proteoform assay and collaborations
Broad-scale assay configuration / technology development
HUPO conference and external validation
Diluted EPS
$-0.11
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Nautilus Biotechnology, Inc. Q2 FY2025 Earnings Call
Confident tone
Customer engagement and collaborations
Platform reproducibility and performance
Tau proteoform manuscript and scientific validation
Diluted EPS
$-0.12
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Nautilus Biotechnology, Inc. Q1 FY2025 Earnings Call
Diluted EPS
$-0.13
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Nautilus Biotechnology, Inc. Q4 FY2024 Earnings Call
Positive tone
Broadscale discovery
Tau proteoform assay
Probe optimization
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-29
Nautilus Biotechnology, Inc. Q3 FY2024 Earnings Call
Cautious tone
Proteoform data and modality progress
Broad scale protein quantification milestone
Proteomics market opportunity
Diluted EPS
$-0.13
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
Nautilus Biotechnology, Inc. Q2 FY2024 Earnings Call
Positive tone
Proteoform Technology
Platform Development Metrics
Product Launch Timeline
Diluted EPS
$-0.14
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
Nautilus Biotechnology, Inc. Q1 FY2024 Earnings Call
Confident tone
U.S. HUPO conference reception
Supply chain and manufacturing readiness
Key opinion leader and researcher engagement
Diluted EPS
$-0.15
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Nautilus Biotechnology, Inc. Q4 FY2023 Earnings Call
Positive tone
Platform Launch Timeline
R&D Progress and Reproducibility
Single-Molecule Protein Decoding
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-31
Nautilus Biotechnology, Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-0.13
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Nautilus Biotechnology, Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-0.13
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Nautilus Biotechnology, Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-0.12
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Nautilus Biotechnology, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Nautilus Biotechnology, Inc. Q3 FY2022 Earnings Call
Diluted EPS
$-0.11
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Nautilus Biotechnology, Inc. Q2 FY2022 Earnings Call
Diluted EPS
$-0.12
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Nautilus Biotechnology, Inc. Q1 FY2022 Earnings Call
Diluted EPS
$-0.13
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Nautilus Biotechnology, Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Nautilus Biotechnology, Inc. Q3 FY2021 Earnings Call
Diluted EPS
$-0.12
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Nautilus Biotechnology, Inc. Q2 FY2021 Earnings Call
Diluted EPS
$-0.19
Audio
Transcript
Slides
8-K10-Q
Showing 1–21 of 21 earnings calls
Key facts
CIK
1808805
CUSIP
63909J108
13F (30d)
13 filings
13 filers
Visit website
Investor relations